David Ginsberg

2.0k total citations
44 papers, 1.4k citations indexed

About

David Ginsberg is a scholar working on Pharmacology, Rheumatology and Psychiatry and Mental health. According to data from OpenAlex, David Ginsberg has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Rheumatology and 9 papers in Psychiatry and Mental health. Recurrent topics in David Ginsberg's work include Pelvic floor disorders treatments (9 papers), Treatment of Major Depression (8 papers) and Urinary Bladder and Prostate Research (7 papers). David Ginsberg is often cited by papers focused on Pelvic floor disorders treatments (9 papers), Treatment of Major Depression (8 papers) and Urinary Bladder and Prostate Research (7 papers). David Ginsberg collaborates with scholars based in United States, Canada and Belgium. David Ginsberg's co-authors include Norman Sussman, Brenda Jenkins, Karl‐Dietrich Sievert, Robert H. Howland, A. John Rush, R.G. Cooke, Mustafa M. Husain, Sonia M. Davis, Mitchel A. Kling and Barry R. Rittberg and has published in prestigious journals such as Biological Psychiatry, Journal of Allergy and Clinical Immunology and The Journal of Urology.

In The Last Decade

David Ginsberg

40 papers receiving 1.3k citations

Peers

Countries citing papers authored by David Ginsberg

Since Specialization

Citations

This map shows the geographic impact of David Ginsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ginsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ginsberg more than expected).

Fields of papers citing papers by David Ginsberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ginsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ginsberg. The network helps show where David Ginsberg may publish in the future.

Co-authorship network of co-authors of David Ginsberg

This figure shows the co-authorship network connecting the top 25 collaborators of David Ginsberg. A scholar is included among the top collaborators of David Ginsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ginsberg. David Ginsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Examination of Patient and Provider Satisfaction, Benefits, and Challenges with Psychiatric Outpatient and Hospital-Based Telehealth Treatment during the COVID-19 Pandemic 2025 ·Psychiatric Quarterly ·(unknown), (unknown), (unknown), (unknown), (unknown), David Ginsberg, Charles R. Marmar, Naomi M. Simon, (unknown), Kristin L. Szuhany	0
2	Perioperative and extended outcomes of patients undergoing parastomal hernia repair following cystectomy and ileal conduit 2024 ·World Journal of Urology ·(unknown), Alireza Ghoreifi, (unknown), Masatomo Kaneko, David Ginsberg, René Sotelo, Inderbir S. Gill, Mihir Desai, Monish Aron, Anne Schuckman, Siamak Daneshmand, Hooman Djaladat	1
3	In-patient psychiatry management of COVID-19: rates of asymptomatic infection and on-unit transmission 2020 ·BJPsych Open ·Emily Zhang, (unknown), (unknown), David Ginsberg, W. Gordon Frankle	14
4	Low Incidence of Clean Intermittent Catheterisation With OnabotulinumtoxinA in Diverse Age Groups of Overactive Bladder Patients With Corresponding Improvements in Urinary Symptoms, Treatment Response, and Quality of Life 2017 ·Neurourology and Urodynamics ·Victor W. Νitti, Marcus J. Drake, Karel Everaert, Eric Rovner, Roger R. Dmochowski, David Ginsberg, Sidney B. Radomski, Tamer Aboushwareb, Cheng‐Tao Chang, Christopher R. Chapple	1
5	Surviving Fournier's gangrene: Multivariable analysis and a novel scoring system to predict length of stay 2017 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·Saum Ghodoussipour, Daniel J. Gould, (unknown), Ido Badash, (unknown), Gus Miranda, Jeffrey Loh-Doyle, Joseph Carey, Hooman Djaladat, Leo Doumanian, David Ginsberg	13
6	Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications 2016 ·Urology ·(unknown), (unknown), J. Quentin Clemens, Kathleen C. Kobashi, Aqsa Khan, Victor W. Νitti, (unknown), Gary E. Lemack, Elizabeth T. Brown, Roger R. Dmochowski, Lara S. MacLachlan, Arthur Mourtzinos, David Ginsberg, Michelle Koski, Ross Rames, Eric Rovner	28
7	Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications 2016 ·Neurourology and Urodynamics ·(unknown), (unknown), J. Quentin Clemens, Kathleen C. Kobashi, Aqsa Khan, Victor W. Νitti, (unknown), Gary E. Lemack, Elizabeth T. Brown, Roger R. Dmochowski, Lara S. MacLachlan, Arthur Mourtzinos, David Ginsberg, Michelle Koski, Ross Rames, Eric S. Rovner	49
8	Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study 2016 ·The Journal of Urology ·Victor W. Νitti, David Ginsberg, Karl‐Dietrich Sievert, David Sussman, Sidney B. Radomski, Peter K. Sand, Dirk De Ridder, Brenda Jenkins, Andrew P. Magyar, Christopher R. Chapple, (unknown)	80
9	Clinically Meaningful Improvements in Urinary Incontinence Following Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study 2015 ·Neurourology and Urodynamics ·Sidney B. Radomski, David Ginsberg, Christopher R. Chapple, David Sussman, Peter K. Sand, Karl‐Dietrich Sievert, Dirk De Ridder, Brenda Jenkins, Yan Zheng, Victor W. Νitti	0
10	MP29-02 (Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate) in the Treatment of Ocular Symptoms of Seasonal Allergic Rhinitis (SAR) 2012 ·Journal of Allergy and Clinical Immunology ·Paul H. Ratner, Eli O. Meltzer, W. David Carr, David Ginsberg	0
11	Vagus Nerve Stimulation for Treatment-Resistant\nDepression: A Randomized, Controlled Acute\nPhase Trial 2005 ·Insecta mundi ·A. John Rush, Lauren B. Marangell, Harold A. Sackeïm, Mark S. George, Stephen K. Brannan, Sonia M. Davis, Robert H. Howland, Mitchel A. Kling, Barry R. Rittberg, W. J. Burke, Mark Hyman Rapaport, John Zajecka, Andrew A. Nierenberg, Mustafa M. Husain, David Ginsberg, R.G. Cooke	416
12	Vagus Nerve Stimulation for Treatment-Resistant Depression: A Randomized, Controlled Acute Phase Trial 2005 ·Biological Psychiatry ·A. John Rush, Lauren B. Marangell, Harold A. Sackeïm, Mark S. George, Stephen K. Brannan, Sonia M. Davis, Robert H. Howland, Mitchel A. Kling, Barry R. Rittberg, W. J. Burke, Mark Hyman Rapaport, John Zajecka, Andrew A. Nierenberg, Mustafa M. Husain, David Ginsberg, R.G. Cooke	18
13	The role of modified-release formulations in hypnotic therapy for insomnia 2005 ·Terry Young, Sanjay R. Patel, David N. Neubauer, David Ginsberg, Eric Hollander	1
14	Optimizing Treatment of Schizophrenia Enhancing Affective/Cognitive and Depressive Functioning 2005 ·CNS Spectrums ·David Ginsberg, Nina R. Schooler, P.F. Buckley, Philip D. Harvey, Peter J. Weiden	25
15	The Differential Diagnosis of Pseudobulbar Affect (PBA): Distinguishing PBA Among Disorders of Mood and Affect 2005 ·CNS Spectrums ·David B. Arciniegas, Edward C. Lauterbach, David Ginsberg, Karen E. Anderson, Tiffany W. Chow, Laura A. Flashman, Robin A. Hurley, Daniel Kaufer, (unknown), Alison J. Reeve, Randolph B. Schiffer, Jonathan Silver	49
16	Treatment-Refractory Epilepsy: An Evidence-Based Approach to Antiepileptic Monotherapy 2005 ·CNS Spectrums ·Cynthia L. Harden, David Ginsberg, Andrés M. Kanner, Jocelyn F. Bautista, Thomas R. Browne	4
17	Women and Anxiety Disorders: Implications for Diagnosis and Treatment 2004 ·CNS Spectrums ·David Ginsberg	26
18	CNS volume 8 issue S12 Cover and Front matter 2003 ·CNS Spectrums ·Robert L. Post, Claudia F. Baldassano, Roy H. Perlis, David Ginsberg	1
19	Hemonectin: a novel hematopoietic adhesion molecule. 1990 ·PubMed ·A. Campbell, (unknown), Wadie F. Bahou, David Ginsberg, Michael W. Long, (unknown)	5
20	Immortalization of human endothelial cells by murine sarcoma viruses, without morphologic transformation 1988 ·Journal of Cellular Physiology ·Douglas V. Faller, Stella Kourembanas, David Ginsberg, Robert L. Hannan, Tucker Collins, Bruce M. Ewenstein, Jordan S. Pober, Ramana Tantravahi	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact